Zurcher Kantonalbank (Zurich Cantonalbank) Axsome Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 5,537 shares of AXSM stock, worth $608,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,537

Previous 7,016 21.08%

Holding current value

$608,350

Previous $593,000 8.77%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$80.05 - $137.75 $118,393 - $203,732	-1,479 Reduced 21.08%	5,537 $645,000
Q4 2024 Feb 07, 2025	BUY	$83.08 - $100.49 $150,956 - $182,590	1,817 Added 34.95%	7,016 $593,000
Q1 2024 Apr 25, 2024	SELL	$69.39 - $97.64 $44,062 - $62,001	-635 Reduced 10.88%	5,199 $414,000
Q4 2023 Jan 30, 2024	SELL	$57.42 - $83.61 $108,523 - $158,022	-1,890 Reduced 24.47%	5,834 $464,000
Q3 2023 Oct 25, 2023	BUY	$69.25 - $82.21 $60,386 - $71,687	872 Added 12.73%	7,724 $539,000
Q2 2023 Aug 07, 2023	BUY	$58.41 - $90.35 $65,944 - $102,005	1,129 Added 19.73%	6,852 $492,000
Q1 2023 May 08, 2023	BUY	$58.39 - $75.0 $60,200 - $77,325	1,031 Added 21.97%	5,723 $352,000
Q4 2022 Feb 01, 2023	SELL	$39.94 - $79.72 $9,545 - $19,053	-239 Reduced 4.85%	4,692 $361,000
Q3 2022 Nov 09, 2022	BUY	$36.06 - $69.85 $42,082 - $81,514	1,167 Added 31.0%	4,931 $220,000
Q2 2022 Aug 09, 2022	SELL	$21.74 - $46.75 $1,369 - $2,945	-63 Reduced 1.65%	3,764 $144,000
Q1 2022 Apr 21, 2022	BUY	$23.7 - $41.39 $19,694 - $34,395	831 Added 27.74%	3,827 $158,000
Q1 2021 May 03, 2021	SELL	$55.91 - $81.44 $30,135 - $43,896	-539 Reduced 15.25%	2,996 $170,000
Q4 2020 Jan 28, 2021	BUY	$66.31 - $86.52 $33,619 - $43,865	507 Added 16.74%	3,535 $288,000
Q2 2020 Jul 28, 2020	BUY	$49.87 - $98.69 $23,488 - $46,482	471 Added 18.42%	3,028 $249,000
Q1 2020 May 06, 2020	BUY	$41.2 - $101.31 $15,367 - $37,788	373 Added 17.08%	2,557 $150,000
Q3 2019 Oct 18, 2019	SELL	$20.24 - $29.16 $12,285 - $17,700	-607 Reduced 21.75%	2,184 $44,000
Q2 2019 Jul 30, 2019	BUY	$13.46 - $25.75 $37,566 - $71,868	2,791 New	2,791 $72,000

Others Institutions Holding AXSM

# of Institutions

409

Shares Held

36.6M

Call Options Held

751K

Put Options Held

568K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.71B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Axsome Therapeutics, Inc. Transaction History